论文部分内容阅读
原发性肝癌是我国常见的恶性肿瘤之一,在我国东南沿海地区发病率尤高.由于发现时多已属于晚期,并发症多,且早期可有肝内转移或门脉癌栓,手术切除率低,常规放疗、全身化疗效果较差,介入疗法有一定效果,但仅适用于早、中期患者,故大多数晚期肝癌的治疗需要临床的进一步研究,去探索行之有效的方法.为此,我们试用大剂量华赡素治疗晚期原发性肝癌,取得良好疗效.现报告如下:
Primary liver cancer is one of the most common malignancies in China. It has a particularly high incidence in the southeastern coastal areas of China. Since it was discovered at the late stage, it has many complications, and there may be early intrahepatic metastasis or portal vein cancer emboli. Low rates, conventional radiotherapy, systemic chemotherapy are less effective, interventional therapy has a certain effect, but only for early and mid-term patients, so the treatment of most advanced liver cancer requires clinical further research to explore effective methods. , We tried high-dose Cinobufotalin to treat advanced primary liver cancer and achieved good results. The report is as follows: